Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancer

BACKGROUND: Prostate-specific membrane antigen (PSMA)-directed radioligand therapy (RLT) is a promising yet not curative approach in castration-resistant (CR) prostate cancer (PC). Rational combination therapies may improve treatment efficacy. Here, we explored the effect of androgen receptor blocka...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:EJNMMI Res
Autori principali: Lückerath, Katharina, Wei, Liu, Fendler, Wolfgang P., Evans-Axelsson, Susan, Stuparu, Andreea D., Slavik, Roger, Mona, Christine E., Calais, Jeremie, Rettig, Matthew, Reiter, Robert E., Herrmann, Ken, Radu, Caius G., Czernin, Johannes, Eiber, Matthias
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer Berlin Heidelberg 2018
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6206308/
https://ncbi.nlm.nih.gov/pubmed/30374743
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13550-018-0451-z
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi